Rainbow Biotech

Rainbow Biotechnology is a Taiwan-based molecular diagnostics company specializing in the development of advanced genetic testing and liquid biopsy solutions. The company's core technology, the Cell-Sifter platform, enables the high-sensitivity detection and analysis of circulating tumor cells (CTCs) from blood samples, providing a non-invasive method for cancer monitoring and personalized treatment selection. Rainbow Biotech offers a comprehensive suite of services, including non-invasive prenatal testing (NIPT), hereditary cancer risk assessment, and companion diagnostics for oncology. As a publicly traded entity on the Taipei Exchange, the company is focused on expanding its diagnostic portfolio and establishing partnerships with clinical institutions to integrate precision medicine into routine oncology care.